IRIS
STAGNO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.546
EU - Europa 960
AS - Asia 835
SA - Sud America 185
AF - Africa 176
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.705
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.499
RU - Federazione Russa 410
SG - Singapore 386
IT - Italia 238
CN - Cina 202
BR - Brasile 161
CI - Costa d'Avorio 111
IE - Irlanda 92
VN - Vietnam 82
IN - India 43
DE - Germania 41
FR - Francia 36
CA - Canada 33
KR - Corea 28
SN - Senegal 28
GB - Regno Unito 27
UA - Ucraina 23
FI - Finlandia 16
IQ - Iraq 14
NL - Olanda 14
SE - Svezia 13
NG - Nigeria 12
TR - Turchia 12
AR - Argentina 11
UZ - Uzbekistan 11
ZA - Sudafrica 10
BD - Bangladesh 9
ES - Italia 9
JP - Giappone 9
MX - Messico 9
KE - Kenya 8
PL - Polonia 8
CZ - Repubblica Ceca 7
AE - Emirati Arabi Uniti 6
HK - Hong Kong 6
BE - Belgio 5
PY - Paraguay 5
AT - Austria 4
MY - Malesia 4
SA - Arabia Saudita 4
DO - Repubblica Dominicana 3
EC - Ecuador 3
GR - Grecia 3
ID - Indonesia 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
NO - Norvegia 3
PE - Perù 3
AU - Australia 2
CL - Cile 2
CY - Cipro 2
EG - Egitto 2
HU - Ungheria 2
JO - Giordania 2
LT - Lituania 2
RO - Romania 2
AZ - Azerbaigian 1
BJ - Benin 1
CH - Svizzera 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
HR - Croazia 1
JM - Giamaica 1
LU - Lussemburgo 1
NP - Nepal 1
OM - Oman 1
PK - Pakistan 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 3.705
Salva come PNG Salva come JPEG
Città #
Singapore 256
Dallas 241
Moscow 206
Santa Clara 205
Chandler 169
Abidjan 111
Chicago 101
San Jose 99
Dublin 91
Ashburn 87
Catania 55
Los Angeles 51
Beijing 49
Hefei 44
Civitanova Marche 33
Boardman 32
Seoul 28
Dakar 27
Lauterbourg 27
Houston 25
Kochi 25
Cambridge 23
Lawrence 23
New York 23
Andover 22
Ho Chi Minh City 21
São Paulo 20
Jacksonville 18
Hanoi 17
Council Bluffs 15
Buffalo 14
Dong Ket 14
Munich 14
Orem 14
Des Moines 13
Grafing 13
Palermo 13
The Dalles 13
Nanjing 12
Wilmington 12
Montreal 11
Columbus 9
Johannesburg 9
Toronto 9
Amsterdam 8
Milan 8
Ottawa 8
Tokyo 8
Brooklyn 7
Turku 7
Abuja 6
Bari 6
Belo Horizonte 6
Hanover 6
London 6
Poplar 6
Saint Petersburg 6
Tashkent 6
Baghdad 5
Boston 5
Curitiba 5
Denver 5
Falls Church 5
Giardini-Naxos 5
Haiphong 5
Helsinki 5
Jiaxing 5
Lagos 5
Nairobi 5
Rio de Janeiro 5
Rome 5
Stockholm 5
Warsaw 5
Asunción 4
Brno 4
Brussels 4
Dubai 4
Elk Grove Village 4
Frankfurt am Main 4
Hebei 4
Hong Kong 4
Jinan 4
Lappeenranta 4
Nanchang 4
Paris 4
Santa Venerina 4
Seattle 4
Acalanes Ridge 3
Atlanta 3
Belém 3
Bremen 3
Florence 3
Istanbul 3
Juiz de Fora 3
Mumbai 3
Osasco 3
Roseto degli Abruzzi 3
Tremestieri Etneo 3
Washington 3
Zhengzhou 3
Totale 2.578
Salva come PNG Salva come JPEG
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 225
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 179
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 167
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 164
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 159
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 154
A case of high-risk AML in a patient with advanced systemic mastocytosis 153
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 152
In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside 149
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 146
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 146
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 145
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 142
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 139
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 137
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 128
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 126
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 125
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 125
Differences among young adults, adults and elderly chronic myeloid leukemia patients 123
Low serum levels of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in IFN-treated chronic myeloid leukemia (CML) patients 121
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 118
Evaluation of taxol cytotoxicity on B-CLL cells in vitro 112
Uncommon long-term survival in a patient with chronic myeloid leukemia 110
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level 102
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 95
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper 73
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions 66
Totale 3.781
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 1 5 16
2021/2022164 4 24 3 3 34 5 27 4 9 1 9 41
2022/2023432 28 48 16 50 31 64 1 80 85 5 18 6
2023/2024251 13 40 8 12 8 66 1 15 5 10 50 23
2024/2025902 12 147 37 83 171 115 77 36 34 52 90 48
2025/20261.755 106 125 264 133 264 460 149 19 124 111 0 0
Totale 3.781